Nosisa Sipambo to Child
This is a "connection" page, showing publications Nosisa Sipambo has written about Child.
Connection Strength
0,238
-
Ongoing High Prevalence of Severe Immune Suppression Among Children in South Africa. J Acquir Immune Defic Syndr. 2023 04 01; 92(4):273-280.
Score: 0,035
-
Abacavir safety and effectiveness in young infants with HIV in South African observational cohorts. Antivir Ther. 2023 02; 28(2):13596535231168480.
Score: 0,034
-
Virologic response of adolescents living with perinatally acquired HIV receiving antiretroviral therapy in the period of early adolescence (10-14 years) in South Africa. AIDS. 2021 05 01; 35(6):971-978.
Score: 0,030
-
Virologic response to efavirenz-based first-line antiretroviral therapy in children with previous exposure to antiretrovirals to prevent mother-to-child transmission. PLoS One. 2020; 15(5):e0233693.
Score: 0,028
-
What Should We Do When HIV-positive Children Fail First-line Combination Antiretroviral Therapy? A Comparison of 4 ART Management Strategies. Pediatr Infect Dis J. 2019 04; 38(4):400-405.
Score: 0,026
-
Lamivudine monotherapy in children and adolescents: The devil is in the detail. S Afr Med J. 2017 Nov 27; 107(12):1055-1057.
Score: 0,024
-
Immunogenicity of 13-valent pneumococcal conjugate vaccine among children with underlying medical conditions. Vaccine. 2017 08 03; 35(34):4321-4329.
Score: 0,023
-
Outcomes in treatment with darunavir/ritonavir in ART-experienced paediatric patients. S Afr Med J. 2015 Apr 08; 105(5):330-1.
Score: 0,020
-
Predictors of loss to follow-up among children in the first and second years of antiretroviral treatment in Johannesburg, South Africa. Glob Health Action. 2013 Jan 24; 6:19248.
Score: 0,017